Zi-Jing Wen

CRISPR‐Cas9 and precision editing technologies linking functional genomics to clinical translation in genetic diseases

The central conclusion is that future CRISPR‐based interventions should be judged not only by editability, but by whether molecular correction can be translated into durable, safe, manufacturable, and clinically meaningful benefit.